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L.Type calcium chalm¢l was expressed in Xem~pus hteris oocytes injected with RNAs coding Ibr different cardiac Ca;" channel subunits, or with 
total heart RNA. The el'fects of activation of protein kin:tse C (PKC) by the phorbol ester PMA (4fl.phorbol 12-mvristate 13.acetate) were studied, 
Currel~ts through chantaels eot'nposed of the re:tin (rt 0 subanit alone were initiall>, increased and Ihen decreased by PMA. A similar biphasie 
modul.'ttion was observed when the rt~ stLbunit w:ts expressed in combin:ttion with er../d~. ,Band/or ~' subunits, and when the channels were expressed 
following, injection or total rat heart RNA. No el'l~ets on the volta~.e dependence of activation were observed. The el'f~ts of PMA were blocked 
by staurosporine, a protein kinase inhibitor. ,a subunit moderated the enhancement caused by PMA. We conclude that both enhancement and 
inhibition of c~irdiae L.t~,'pe Ca"" currents by PKC are mediated via an effect orl the et z subunit, while th¢,O subunit may play a tllild modulatory 
role. 
Calcium eham~el: Cah:ittm ch~mncl subunit: Proteit~ kinase C: Phorbol ester: Xenolm.~" oocyte 
!. INTRODUCTION 
The dihydropyridine (DHP)-sensitive L-type Ca-'" 
channel carries a major part of Ca "-~ current in skeletal, 
smooth and cardiac muscle [1,2]. This chatanel is one of 
the main targets of the various physiological modula- 
tors in these tissues [!,3-5]. The cardiac Ca-'* current is 
modulated by the protein kinase C (PKC) cascade, 
which may mediate the physiological effects of angio- 
tensin I! and ~l-adrenergic agonists in the heart [6,7]. 
The effect of phorbol esters (PKC activators) such as 
fl-phorbol ! 2-m),ristate 13-acetate (PMA) on cardiac L- 
channel is biphasic: the Ca -'* current is initially en- 
hanced but, after several minutes, inhibition of Ca -'+ 
current Ibllows [7,8]. 
The L-type Ca-'* channel fi'om skeletal muscle (SKM) 
consists of 5 subunits [5,9,10]: 0:t (165 kDa); 0L,/c~ (130/28 
kDa),/~ (55 kDa), and 2, (32 kDa). Identical or homol- 
ogous proteins, except 7', are found in the heart (0:~, =.,/& 
/3) [11-18]. The ~ subunit is the main, pore-forming 
subunit [5,19,20-23]. It produces functional Ca -'+ chan- 
nels when expressed in various eapression systems uch 
as oocytes and cell lines [11,24--27]. The roles of other 
('auxiliary') subunits are less well understood. Studies 
in RNA-injected Xenopus oocytes have demonstrated 
that 0c,/~ and SKM ,8 (,81) or cardiac fl subunits ~2a, 
fl2b, ,6'3) enhance the expressed Ca :÷ current amplitude 
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[11,24,25,28-33]. The auxiliary subunits also modulate 
activation and inactivation kinetics and voltage sensitiv- 
ity of Ca -'" channels in expression systems [29-31]. 
The phosphorylation f which subunit mediates the 
physiological effect of PKC activators i not clear. The 
biochemistry of in vitro phosphorylation of L-channel 
is documented only in skeletal muscle (SKM), where a 
naembrane-associated form of ~ subunit is efficiently 
phosphorylated by PKC [34,35]. The/3 subunit is rich 
in putative PKC phosphorylation sites [13] and is a 
substrate for PKC phosphorylation [34-36]. Thus, 
phosphorylation f either cz~ or t5' could account for the 
physiological effect of PKC on cardiac Ca"* current, 
and it is even theoretically possible that the biphasic 
effect of PKC activators might be due to PKC action on 
different subunits. 
The present study examines the roles of Ca -'* channel 
subunits in determining the effects of a PKC activator, 
PMA, on cardiac L-type Ca :+ channels expressed in 
Xettoptts oocytes. We find that a channel composed of 
cardiac ~t subunit alone is modulated by PMA in a 
biphasic manner (increase followed by a decrease), like 
in the heart, and that the auxiliary subunits may at most 
exert moderate modulatory effects. 
2. MATERIALS AND METHODS 
Frog~ were maintained and dissected as described 139.40]. The frogs 
were dissected under MS-222 anesthesia. Pieces of ovarian lobes were 
removed via small incisions on the belly: the latter was sutured, and 
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tile animals crete returned to the tanks after recovering fro,a~ aneslhe- 
sia (see [40] for details). Ooeytes were defolliculated by a 2. to 3.h 
treatment with 1.5-2 mg/ml collagenas¢ (Type IA, Sigma) in Ca-free 
ND96 solution (in raM): 96 NaCI, 2 KCI. 1 MgCI,. 5 HEPES/NaOH, 
pH 7.5. Clones of rabbit cardiac 0q [ 16] and fl2a [28] and of SKM 0L,/d;, 
01 and >, subunits [13,15,29] were used to s),nthesize cRNAs in vitro 
and then the cRNA was injected into Xeltoptts oocytes. Equ01 doses 
(5 ns/ooc)'te) of each sabanit were injected in different combinations 
in u total volume of' water of 50 hi. Total RNA was extracted from 
rat (7 days o!d) hearts usinl~ LiCl procedure as described [40] (rats were 
anesthetized with ether and sacrificed by decapitation). After 2--4 days 
of incubation at 22°C in ND96 containing 1.8 mM CaCI, aud antibi- 
otics [40]. one day before testing the currents, the oocytes were injected 
with 200 or 400 Drool ethyleneglycerol-bis-~-aminoethyl ether)- 
N,N,N',N',.tetraacetlc acid (EGTA; Na ~alt. pH 7) using standard 
injection techniques [,10]. The currents through the channels were 
measured usine, tl~e two.electrode vohage.clamp tedmique, routinely 
in a solution containing (in mM): 40 BaCI.~, 2KCI. 60 NaCI, 5 HEPES/ 
NaOH, pH 7.5. When the curreuts exceeded 2 #A in the high-Be z" 
solution. 2 mM BaCk, solution was used (Ca-fl'ee ND96 with the 
addition of 2 mM BuCI.9. Currents in oocytes injected with rat heart 
RNA were measured in the Btt/NMDG solution (in raM: 40 Ba '÷, 60 
NMDG. 2 K', 5 HEPES/NaOH, pH 7.5) in which N£ was substituted 
by N-methyl-D-81ueamine (NMDG) and the only anion was methane. 
sulfonate [41]. The two-electrode voltage-clamp data analysis and 
subtraction procedures were as described [29,421. After setting the 
membrane potential t the holding level (-80 mV), stabilization fthe 
ga "~' current ([.0 was verified by constant monitoring of the current 
for 10-40 mix (1~, often grew for up to 30 mix until reaching a constant 
value; ~e¢ [29]). In order to overcome problems of Ba"*-dependent 
decrease in I,~ amplitude observed incells with large currents upon 
fi'equent repetitive depolarizations, interpulse intervals that allowed 
a full recovery of I~, (30-60 s, dependina on current amplitude) were 
used [29]. The membrane capacitance wa~ measured as the integral of 
the capacltatlvc current evoked by a voltage step from -80 to -70 m'V. 
4~.phorbo112-myristate 13-acetate (PMA)and staurosporinc were 
from Sigma. 4ct.phorbol 12-myristat¢ 13.acetate (~r-PMA) was from 
LC Services. These substances were dissolved at 10 -~" M in dimcth- 
ylsulfoxide (DMSO) and stored in llght-protected vials at-20°C. Final 
concentration was prepared shortly before ach experiment. 
3. RESULTS 
Oocytes injected with RNA of the cardiac czt subunit 
alone or in combination with a mixture of  ~_4& fl, and 
y subunit RNA displayed Ba 2. currents (Fig. 1) which 
we have previously shown to be dihydropyridinc-scnsi- 
tire [29]. Oocytes injected with a mixture of  ~2/& and fl l 
(SKM) or fl2a (cardiac) subunit RNA, without the car- 
diac cx~ subunit, expressed quite large currents (20-100 
nA with ,61 and 150-300 nA with fl2a in a 40 mM Ba ~'* 
solution; Fig. I B). These currents were unaffected by 
the dihydropyridine agonist ( - )  Bay K 8644 (1 tiM) and 
the antagonist isradipine (10 ~tM) (data not shown; cf. 
[29]) and most probably resulted from the association 
of the newly synthesized ~,_/6 and fl subunits with a 
native DHP-insensitive tz~ subunit already existing in 
the oocyte [29,33]. In oocytes injected with subunit com- 
binations containing cardiac ~ In., was enhanced by ( - )  
Bay K 8644 and blocked by 80-95% by 10 btM isradip. 
ine (data not shown). Therefore, the contribution of the 
oocyte's native (DHP-insensitive; see [41--45]) current in 
these cases was minor or negligible. In most oocytes 
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Fig. 1. Examples of 4;~, obtained in a 40 mM BaCI~ solution by steps 
from -1O0 mV to 0 mV before and after PMA (10 nM) application 
in oocytes of different groups (subuuit combinations) as indicated. 
Dariug the experiment the holding potential was -80 inV. Net I~ was 
obtained by Cd-.-ubtraetion procedure (subtraction o1" currents re- 
corded after addition of 400/aM CdCI, to the recording solution; see 
[291. 
injected with rq subunit RNA alone, In, was rather 
small (5--40 hA), and the experiments were performed 
in the presence of  0.5/.tM ( - )  Bay K 8644. 
Fig. 1 shows typical Ba ~-' currents in oocytes injected 
with four different Ca 2+ channel subunit combinations 
('groups'), and illustrates the effect of PMA. The kinet- 
ics of  the currents were not considerably affected by 
PMA, whereas the amplitude was dramatically 
changed. The time course of  PMA effect in different 
groups is exemplified in Fig. 2. In 64 (out of  65 tested) 
oocytes of all groups, PMA (10 aM) caused a transient 
increase in In,. The current amplitude began to increase 
1-2 rain after PMA application (or, in a few cells, after 
a slight decrease that lasted for 1-2 mix ), and reached 
a maximum after 7-12 min. None of the auxiliary sub- 
units appeared to play an exclusive role in determining 
the time course of  the enhancement caused by PMA 
(summarized in Table I). The extent and duration of the 
increase varied among oocytes of each group. Alto- 
gether, lt~, was increased by 131% in the ~t group and 
by 142% in the ~l+ct,./6 group (Table I). This is signifi- 
cantly stronger than in the groups that differ by the 
addition of the/~ subunit. Thus, in the ~l+pl  group the 
current was increased by 58% (P<0.02 compared with 
~z~); in the gt-t-g2/c~+fll and a~+a.,/t~+,82a groups the cur- 
rent was increased by 58% and 52%, respectively (in 
both cases /'<0.02 compared with ~+=,/~;  Table I). 
Thus, the fl subunit appears to restrain the enhancing 
effect of  PMA. 
Typically, in cardiac ~xj-containing groups, the cur- 
rent started to decrease shortly after reaching a maxi- 
mum and by 30 mix after PMA application decreased 
114 
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Fig. 2, Examples of the ¢tTeci of PMA (10 nM) on Its,, and the mem- 
brane capacitance as a function of time. The ltj. (open circles) and 
capacltance (closed circles) values arc shown in percents of the control 
values (Ihe basal current amplitude and the basal membrane capaci- 
tance, before PMA applic:ttion). 0 mln indicates the PMA application 
time, r.. in this figure stands for :14~. 
below the control level (Fig, 2A,B,D,E). However, in 
some cells the decrease was delayed, as exemplified in 
Fig. 2C. In order to verify that the decrease in lm by 
PMA was not a re.~ult of an accompanying reduction in 
the membrane surface area [46], the membrane capaci- 
tance was monitored along with the development of 
PMA effect on In,,, The capacitance was unchanged or 
slightly increased (after 10 rain in PMA, it was 105_+2% 
of control, n=56; after 30 rain in PMA, it still was 
105__.2% of control, n=39; see Fig. 2), and only later 
returned to the control level or dropped below it (e.g, 
Fig. 2C). In most oocytes, even 50 rain of PMA applica- 
tions did not change the membrane capacitance by more 
than 10% below the control level (el. [47]). Ooeytes in 
which the capacitance decreased by more than 10% 
after 30 rain were discarded. 
Quantification of the inhibitory effect of PMA was 
PMA (2s minutes) 
control 
= PMA (6 minutes) 0 
u3 
0.5 see 
Fig. 3. The effect of PMA (50 nM) on I~, expressed in oocyte injected 
with rat heart RNA, Net In. was obtained by Cd-subtraction proce- 
dure in 40 mM Ba-methanesulfonate solution (see section 2). The 
holding potential was -50 mV and the current was elicited by steps 
from -10t3 mV to 0 mV 
done by comparing I~. 30 rain after PMA application 
in oocytes of different groups, as summarized in Table 
1 (cells with delayed ecrease were summarized sepa- 
rately from the 'typical' cells in which the current was 
decreased below the control evel by 30 min). The extent 
of PMA-induced ecrease was similar in all ~zrcontain- 
ing groups except hose of the ~q+~:/d;+T group (Table 
I). 
• PMA caused a similar biphasic effect in oocytes in- 
jected with rat heart RNA: a transient increase in lb. 
which was followed by a sustained ecrease (Fig. 3; 
.=4). Another phorbol ester, 4/~-phorbol dibutyrate. 
have been previously reported to cause similar effects in 
heart RNA-injected oocytes [.48]. 
In contrast o groups that contained cardiac ~tt, in 
oocytes that did not contain this subunit (groups cx_4 
~+/~1 and ~48+f12a), even a sustained PMA application 
did not cause any decrease in I~ below the control evel 
for up to 40 min (Figs. t Batld 2F, and Table I). In 
addition, we noticed a slowing of the rate of decay of 
Table I 
Effects of 10 nM PMA on I.. in oocytes injected with various Ca -` + channel subanit combinations {groups) 
Group Maximal increase Time to maximal 
in Its. (% above control) increase (rain) 
In 30 min after PMA (% of control) 
Typical cells Cells with delayed ecrease 
0:~ 131_+26 (11.6) 11+-! (11.6) 71__. 8 (6.3) 169 + 10 (4.3) 
c~t+a~/~ 142_+31 (14.6) 13+1 (14.61 74+_ 6 (9.5) 109_204 (2.2) 
ct~+fll 58_+ 6 (6.2) 7+1 (6.2) 65_+13 (4.1) 120 (I.1) 
~+~,/8+fll 58+_10 (18.4) 11_+1 (7.4) 56___ 6 (7.5) 149+ II (5.11 
:r,e~./d~+/32a 52+14 (7,2) 9+1 (7.2) 56_+ 2 (5) - -  
~t÷~:/8+T 143_+34 (8.3) l l+-i (8.3) 88+13 (6.2) 143_+ 12 (4.2) 
~x:÷fll 100_+12 (4,1) 8±1 (4.1) 145-+ 2 (3.1) - 
~,+p2a 55-+11 (4.2) 9+_1 (4.2) 125+_ 7 (3.1) - -  
The entries are mean __. S,E,M. (number of oocytes, number or frogs). The currents were evoked by steps from - 10O to 0 mV, Net It~ was estimated 
by a leak subtraction procedure: leak current evoked by a step from -I00 to -50 mV was scaled up and subtracted from the total current measured 
at 0 inV. In most cells of the a~ group, the experiments were performed in the presence of 0,5 btM (-) Bay K 8644, 
I15 
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Fig, 4. Current-voltage curves in the presence and absence of PMA. 
Net/'~, evoked by depolarizing pulses to differe,at voltages were nw:~s- 
ured by the Cd.subtraction procedure us explained in legend to Fin. 
1, The data was fitted to a modified ~,oJtz:~aam~ equation us de.~crlb~.d 
by Daseal :rod Lotan [47]. assuming two activating ates: 
I=G,.~.[ 1/.,, - V,}/[ 1 +exp(( V,- I.',.}/K~,)) ~', 
where if,. is the me,'nbru,ae voltage, a,ad G ....... I~,. K,, wad G are as 
explained in the text. Circles show the control curve [bclbre PMA 
applicatlon); trlan81es, durha~ the enhancement phase of the current 
(shortly after PMA applie~ttion): squares, during the inhibitory phase 
of the PMA effect. In A, the parameters V, (mV), G ...... (,uS). V, [mV) 
and K~, [mV) were 69. 3,1. -6,7.8,7 in control: 67.6,2, -6. 9.7 during 
the enhancement phase; 63. 2.7, -5, 11 during the inhibition phase. 
In B, the parameters were 66, 41, 1,2. 10 in control; 65. 70, I.I, 10,3 
durir~g the enhancement phase: 65, 31. 1. 10,6 during the inhibition 
phase, In C. the parameters were 64, 41, -7,3, 7,2 in control: 63, 73. 
-4.9, 7.5 during the e,ahaneement phase: 60. 41, -3.9, 7.9 during the 
inhibition phase, 
lu,, by PMA in these groups (e.g. Fig. 1), but this phe- 
nomenon was not analyzed further. 
To examine the effect of  PMA on the voltage depend- 
ence of Ca-'* channel activation, current-voltage (I-I0 
curves obtained in individual oocytes were fitted to the 
Boltzmann equation (Fig. 4) as described previously 
[41] in control and during the PMA-induced increase 
and then decrease of It3,. The description of the activa- 
tion in terms of the Boltzmann equation was a conven- 
ient way to compare the prol~erties of channels before 
and after PMA application, without bearing on any 
specific gating mechanism (see [49]). PMA did not cause 
any changes in the V, (reversal potential), ~ (half-acti- 
vation voltage) or K, (the slope factor, inversely related 
to the steepness of the activation curve). The only pa- 
"Fable 11 
Parameters ol'voha,~e dependence ofactivation of I.. in groups ~t~ and 
~t+rt,/8 in the absence and presence of PMA 
rameter that was changed UpOll PMA ~tpplication was 
G,,~,,~ (maximal m:tcroscopic Ba-" conductance)[Tztble 
IlL 
Two types of control experiments have been under- 
taken in order to assure that PMA action on Bu-'" cur- 
rents was via PKC activation. (i) PMA ~ction on Its:, in 
oq+o~,./8 and ~,,~J~+fl l  groups was tested in the pres- 
ence of staurosporine (1 ,aM), a potent protein kinase 
inhibitor. All measurements were done during a two- 
day experime,at in oocytes of the same fi'og, in order to 
avoid the frog-to-frog variability (Table III). Stauro- 
sporine attenuated the PMA-induced increase in Ira, by 
65% in both ~t+~,_/b" and ~t+0~J6+f l l  groups (Table III; 
P<0.05), an0 alao weakened by 82% the decrease meas- 
ured 30 rain after PMA application (tested only in the 
~l+~:/8+fll group) (Table 1II; P<0.05). We note, how- 
ever, that even in the presence of staurosporine, after 30 
rain at which the measurements were taken, In,, contin- 
ued to decrease at a slower rate in the following 20-30 
rain, so that the main effect of staur0sporin¢ actually 
was a slowing down of the inhibitory effect of PMA. (ii) 
4=-PMA (10 nM), an inactive PMA isomer that does 
not activate PKC, did not alter lt~, in ~t+~,./8 and =~ +c¢,./ 
8+,6'1 groups (Table 111). 
4. DISCUSSION 
in this study we addressed two questions: (i) whether 
it is possible to study modulation of ¢~rdiac Ca -'~ chan- 
nels by PKC in Xenopus oocytes; (ii) which of the car- 
diac L-type Ca'* channel subunits is the target for PKC 
action. The answer to the first question is positive: the 
cardiac Ca -'~ channel expressed in the oocytes is modu- 
lated by the phorbol ester PMA in the same way as in 
single canine ventricular and Purkinje cells [7] and in 
primary cultures of neonatal rat ventricular myocytes 
[8]. Moduhttion by PMA was similar in Ca -~ channels 
expressed after the injection of either total heart RNA 
or the cRNA mixtures of the different channel subunits. 
Table I11 
Verification of specificity of PMA aft'eeLs with stau,'osporlne and ~- 
PMA 
Group Tl'e~lt rnent 
Group and conditions V, G ...... |C, K. ~t ~+~.,/6 
"q+~:,/8 control 65+_3 27-+4 0,5+2 9+1 7 
~t+~,/J-enhancement phase 65_+2 50_+8 0.9_+1 10+1 6 
er,+~.4~r-inhlbitory pirate 62+1 17+_3 0.9_+2 10+1 7 
¢~ ¢onlrol 58+3 4__.0,2 -3_+1 10+1 3 
g¢enhancement phase 60-+5 6+0.4 -4+1 10__.1 3 
=:inhibitory phase 56+5 34-0,1 -2__.2 I1+1 3 
The entries are mean -+ S.E.M. (number of ooeytes). 1~, G,.,, V, ,'t ~d 
/q. are as explained in the text. 
lj~. during maxi- 
mal enhancement 
[% of control) 
1,,, 30 rain after 
PMA application 
[% of control] 
~q +rt,_lS-~ffl 
PMA 262+_41 (4) 
PMA+staurosporine 158+ 9 [4) 
,v.PMA 1054_ 3 (4) 104 + 5 (4) 
PMA 181+11 {6) 49_12 (3] 
PMA+staurosporirte 128_+16 [3) 9Ix 5 [3) 
a-PMA 108_+13 (6) 98 + 2 (4) 
The entries are mean + S.E.M. (number of ooeytes). The effects of 
stuurosporine were tested in oocytes oi" the sana¢ frog and in the same 
experiment as the control current, to avoid frog.to.fro $ variability. 
The effects of,v-PMA were te~ted in a separ:lte xperiment. 
i16 
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In both cases PMA caused an increase and then a de- 
crease of the DHP-sensitive current. These effects could 
not be mimicked by inactive isomer of  PMA, a -PMA,  
and were substantially blocked by a PKC inhibitor, 
staurosporine. These results suggest hat the oocyte can 
be used for further studies of  the molecular mechanisms 
of  Ca'*  channel modulation by PKC. 
The answer to the second question was obtained in 
experiment~ in which channels composed of various 
subunit combinat ions were challenged with PMA. The 
biphasic effect o f  PMA was observed in oocytes injected 
with cardiac cxt alone, and this suggests that the g~ 
subunit is the main target of PKC action in the Ca "-+ 
channel, This is the main finding of this study. It is not 
clear whether the effect of PMA is due to a direct phos- 
phorylat ion of  aj or via an additional protein. This 
should be clarified in further studies aimed at finding 
the exact phosphorylat ion site or sites of  PKC. 
The presence of  the other auxiliary subunits of  the 
Ca '-+ channel hardly altered the PMA effect: a, /~ sub- 
units did not influence it at all. whereas the fl subunit 
reduced the extent of Ba -'+ current potentiation caused 
by PMA. "Thus, the fl subunit may play a modulatory 
role. A simple scenario may be thatf l  is phosphorylated 
at one or more of  the many putative PKC phosphoryl-  
ation sites [13,28], and the resulting conformational 
change affects (reduces) its coupling to gt, or causes in 
turn a conformational  change in g~ followed by an alter- 
nation in the channel function. Another possible mech- 
anism for such modulat ion may be a simple competit ion 
between ~. and ,6 for the available PKC molecules, re- 
suiting in less phosphorylation of  ~ ,  
The presence of the 7' subunit attenuated the inhib- 
itory effect of PMA,  suggesting that this subunit may 
also have a modulatory role. However, since 7 subunit 
has not been found [14.15] in the cardiac Ca -~" channel. 
it is difficult to assign any physiological role to this 
effect. 
PMA did not alter the parameters of the voltage de- 
pendence of activation of the cardiac Ca-" channel. The 
only parameter  that was changed was G.~ .... (maximal 
macroscopic onductance) which might result fi'om an 
increase in the number of Ca '-+ channels opened, or 
from an increase m the open time o1" probabil ity of 
opening of  the channel. 
Oocytes injected with ~,./c~+fl subunits displayed a 
DHP-insensit ive Ba :~- current most probably due to 
their coupling to the endogenous DHP-insensitive cxj 
~ubunit (of. [29,33]). When fl2a was present, the ampli- 
tude of this current was higher than when the channel 
contained i l l .  We conclude that/~/2a subunit links more 
efficiently to an endogenous g~ subunit protein to form 
a functional channel. In oocytes injected with ~./8+// 
fill or/~2a) subunits cRNA,  PMA caused only an in- 
crease of  la~. This finding supports the notion that the 
pore-lbrrning subunit o f  these channels is the en- 
dogenous oct subunit, since PMA has been reported to 
enhance the oocytc's endogenous lj~ [45]. in addition, 
it suggests that the decrease of the current by PMA in 
channels containing the cardiac DHP-sensitive at was 
a specific effect of PKC on the a. subunit rather than 
a side effect of PKC cn internalization of the mem- 
brane, which could also result in a decrease in lug. 
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